Author

Zefei Jiang

Institution: Chinese PLA General Hospital

Observed institution: Chinese PLA General Hospital

OpenAlex ID: A5159217543

Sacituzumab govitecan plus toripalimab compared with toripalimab plus nab-paclitaxel for first-line treatment of unresectable, locally advanced, or metastatic triple-negative breast cancer: protocol of a multicenter, open-label, randomized phase II trial

2026 · Shaohua Zhang, Jianli Zhao, et al. · Translational Breast Cancer Research

Works count: 1

Citation count:

H-index:

I10-index: